San Diego, CA—Artemis Research is pleased to announce that the Teva TV46000-CNS-30072 RISE Schizophrenia clinical trial Artemis participated in was a success! Teva Pharmaceuticals Industries and its partner MedinCell announced positive results for this … Ver Mas
Headlands Research visualiza la trayectoria de innovación y crecimiento con la adquisición del Instituto Artemis de Investigación Clínica de varios sitios con sede en el sur de California
SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) — “Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that it has acquired Artemis Institute for Clinical Research. The acquisition significantly strengthens Headlands’ … Ver Mas
Artemis Research nombrado Equipo del Año del Sitio Clínico 2020 por PharmaTimes
San Diego, CA—The prominent clinical research company, Artemis Research, was announced as the winner of the highly coveted Site Team of the Year award on October 20, in the 10th Annual Ceremony of Pharma Times … Ver Mas
Artemis Research Compite en el Sitio de Investigación Clínica del Año de Pharma Times
Artemis Research has a team competing in the Pharma Times Clinical Research Site of the Year competition. Throughout these past few months, they have made it to the FINALS! A huge shoutout to Team … Ver Mas
Dr. Vishaal Mehra es Reconocido Como Uno de los 20 Principales Directores Ejecutivos Pioneros del 2020
My Tech Magazine has recognized our CEO, Dr. Vishaal Mehra, as among the Top 20 Pioneering CEOs of 2020! “Our ambition at Artemis is to drive forward a more effective and sophisticated way to … Ver Mas